Drug Shortage Report for LUPIN-CEPHALEXIN
Report ID | 172209 |
Drug Identification Number | 02469189 |
Brand name | LUPIN-CEPHALEXIN |
Common or Proper name | Lupin-CEPHALEXIN |
Company Name | LUPIN PHARMA CANADA LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | CEPHALEXIN |
Strength(s) | 250MG |
Dosage form(s) | POWDER FOR SUSPENSION |
Route of administration | ORAL ORAL |
Packaging size | 100 ml and 150 ml |
ATC code | J01DB |
ATC description | OTHER BETA-LACTAM ANTIBACTERIALS |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | |
Actual start date | 2022-10-19 |
Estimated end date | 2023-02-28 |
Actual end date | 2023-01-01 |
Shortage status | Resolved |
Updated date | 2024-02-14 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 550-1111 RUE ST-CHARLES OUEST LONGUEUIL, QUEBEC CANADA J4K 5G4 |
Company contact information | lupin@lsu3pl.ca (Customer service / Service à la clientèle) |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2022-10-19 | English | Compare |
v2 | 2022-10-19 | French | Compare |
v3 | 2022-10-20 | English | Compare |
v4 | 2022-11-01 | English | Compare |
v5 | 2022-11-01 | French | Compare |
v6 | 2022-12-08 | English | Compare |
v7 | 2023-01-16 | English | Compare |
v8 | 2024-02-14 | English | Compare |
Showing 1 to 8 of 8